Validity and Future of Primary Androgen Deprivation Therapy in Prostate Cancer. Integration in the Era of New Agents Targeting the Androgen Receptor

Joaquin Carballido

PDF(886 KB)
Archivos Españoles de Urología ›› 2023, Vol. 76 ›› Issue (1) : 1-28. DOI: 10.56434/j.arch.esp.urol.20237601.1
Review

Validity and Future of Primary Androgen Deprivation Therapy in Prostate Cancer. Integration in the Era of New Agents Targeting the Androgen Receptor

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 76(1): 1-28 https://doi.org/10.56434/j.arch.esp.urol.20237601.1

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
Article Options
  • PDF (130 views)
  • Full Text ( views)

Accesses

Citation

Detail

Sections
Recommended

/